Tofacitinib 70710-1727-03
- Manufacturer
- Zydus Pharmaceuticals Usa Inc.
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 20, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA214264
Need to source Tofacitinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tofacitinib Citrate | 22 mg/1 |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]
Selected Package
70710-1727-03Selected30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70710-1727-3)
Other packages for this product(1)
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70710-1727-9)